Basic Information
RNALocate ID: RLID:11001508
RNA Symbol: hsa-miR-214-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-214-3p
RNA ID: miRBase:MIMAT0000271
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23663360
Tissue/Cell Line: Plasma
Method: Next-generation RNA sequencing
Description: Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001658 Cytoplasm Nasopharyngeal carcinoma cells 20498841
RLID:01001659 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01001660 Nucleus Nasopharyngeal carcinoma cells 20498841
RLID:11001505 Exosome Primary ovarian tumor cells|Serum 18589210
RLID:11001506 Exosome Plasma 19289371
RLID:11001507 Exosome Brain tissue 23382797
RLID:11001509 Microvesicle Follicular fluid 23666971
RLID-D:11000332 Microvesicle Fibroblasts|Mesenchymal stem cells
RLID-D:11001171 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-214-3p Multiple sclerosis chronic progressive MNDR-E-MI-29054
MNDR hsa-miR-214-3p Oral squamous cell carcinoma MNDR-E-MI-29055
MNDR hsa-miR-214-3p Large cell neuroendocrine cancer MNDR-E-MI-29056
MNDR hsa-miR-214-3p Medulloblastoma MNDR-E-MI-29057
MNDR hsa-miR-214-3p High-grade serous ovarian carcinoma MNDR-E-MI-29058
MNDR hsa-miR-214-3p Ovarian clear cell carcinoma MNDR-E-MI-29059
MNDR hsa-miR-214-3p Uterine corpus endometrial carcinoma MNDR-E-MI-29060
MNDR hsa-miR-214-3p Lymphoma MNDR-E-MI-29061
MNDR hsa-miR-214-3p Estrogen-receptor positive breast cancer MNDR-E-MI-29062
MNDR hsa-miR-214-3p Estrogen-receptor negative breast cancer MNDR-E-MI-29063
MNDR hsa-miR-214-3p Progesterone-receptor negative breast cancer MNDR-E-MI-29064
MNDR hsa-miR-214-3p Triple negative breast cancer MNDR-E-MI-29065
MNDR hsa-miR-214-3p Myeloid neoplasm MNDR-E-MI-29066
MNDR hsa-miR-214-3p Dermatomyositis MNDR-E-MI-29067
MNDR hsa-miR-214-3p Prostate cancer MNDR-E-MI-29068
MNDR hsa-miR-214-3p Gastric cancer MNDR-E-MI-29069
MNDR hsa-miR-214-3p Alzheimer disease MNDR-E-MI-29070
MNDR hsa-miR-214-3p Bladder cancer MNDR-E-MI-29071
MNDR hsa-miR-214-3p Sarcoma MNDR-E-MI-29072
MNDR hsa-miR-214-3p Dysautonomia familial MNDR-E-MI-29073
MNDR hsa-miR-214-3p Polycystic ovary syndrome MNDR-E-MI-29074
MNDR hsa-miR-214-3p Muscular dystrophy duchenne MNDR-E-MI-29075
MNDR hsa-miR-214-3p Facioscapulohumeral muscular dystrophy MNDR-E-MI-29076
MNDR hsa-miR-214-3p Head and neck cancer MNDR-E-MI-29077
MNDR hsa-miR-214-3p Huntington disease MNDR-E-MI-29078
MNDR hsa-miR-214-3p Chorea MNDR-E-MI-29079
MNDR hsa-miR-214-3p Cardiovascular disease MNDR-E-MI-29080
MNDR hsa-miR-214-3p Lung cancer MNDR-E-MI-29081
MNDR hsa-miR-214-3p Parkinson disease MNDR-E-MI-29082
MNDR hsa-miR-214-3p Breast cancer MNDR-E-MI-29083
MNDR hsa-miR-214-3p Squamous cell carcinoma MNDR-E-MI-29084
MNDR hsa-miR-214-3p Vascular diseases MNDR-E-MI-29085
MNDR hsa-miR-214-3p Pituitary neoplasms MNDR-E-MI-29086
MNDR hsa-miR-214-3p Pancreatic cancer MNDR-E-MI-29087
MNDR hsa-miR-214-3p Melanoma MNDR-E-MI-29088
MNDR hsa-miR-214-3p Rectum adenocarcinoma MNDR-E-MI-29089
MNDR hsa-miR-214-3p Nephroblastoma MNDR-E-MI-29090
MNDR hsa-miR-214-3p Colon cancer MNDR-E-MI-29091
MNDR hsa-miR-214-3p Ischemic attack transient MNDR-E-MI-29092
MNDR hsa-miR-214-3p Colon adenocarcinoma MNDR-E-MI-29093
MNDR hsa-miR-214-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-29094
MNDR hsa-miR-214-3p Ovarian cancer MNDR-E-MI-29095
MNDR hsa-miR-214-3p Kidney cancer MNDR-E-MI-29096
MNDR hsa-miR-214-3p Carcinoma ductal breast MNDR-E-MI-29097
MNDR hsa-miR-214-3p Glioblastoma MNDR-E-MI-29098
MNDR hsa-miR-214-3p Glioma MNDR-E-MI-29099
MNDR hsa-miR-214-3p Chronic obstructive pulmonary disease MNDR-E-MI-29100
MNDR hsa-miR-214-3p Nemaline myopathy MNDR-E-MI-29101
MNDR hsa-miR-214-3p Central nervous system lymphoma MNDR-E-MI-29102
MNDR hsa-miR-214-3p Rhabdomyosarcoma MNDR-E-MI-29103
MNDR hsa-miR-214-3p Amyotrophic lateral sclerosis MNDR-E-MI-29104
MNDR hsa-miR-214-3p Epilepsy temporal lobe MNDR-E-MI-29105
MNDR hsa-miR-214-3p Osteosarcoma MNDR-E-MI-29106
MNDR hsa-miR-214-3p Liposarcoma MNDR-E-MI-29107
MNDR hsa-miR-214-3p Coronary artery disease MNDR-E-MI-29108
MNDR hsa-miR-214-3p Inclusion body myositis MNDR-E-MI-29109
MNDR hsa-miR-214-3p Gastric adenocarcinoma MNDR-E-MI-29110
MNDR hsa-miR-214-3p Pituitary adenoma MNDR-E-MI-29111
MNDR hsa-miR-214-3p Non-small cell lung cancer MNDR-E-MI-29112
MNDR hsa-miR-214-3p Lung adenocarcinoma MNDR-E-MI-29113
MNDR hsa-miR-214-3p Adrenocortical cancer MNDR-E-MI-29114
MNDR hsa-miR-214-3p Thyroid carcinoma MNDR-E-MI-29115
MNDR hsa-miR-214-3p Ovarian carcinoma MNDR-E-MI-29116
MNDR hsa-miR-214-3p Bladder urothelial carcinoma MNDR-E-MI-29117
MNDR hsa-miR-214-3p Pancreatic adenocarcinoma MNDR-E-MI-29118
MNDR hsa-miR-214-3p Scleroderma MNDR-E-MI-29119
MNDR hsa-miR-214-3p Cervical cancer MNDR-E-MI-29120
MNDR hsa-miR-214-3p Carcinoma renal cell MNDR-E-MI-29121
MNDR hsa-miR-214-3p Kidney renal papillary cell carcinoma MNDR-E-MI-29122
MNDR hsa-miR-214-3p Clear cell renal cell carcinoma MNDR-E-MI-29123
MNDR hsa-miR-214-3p Chromophobe renal cell carcinoma MNDR-E-MI-29124
MNDR hsa-miR-214-3p Pancreatic carcinoma MNDR-E-MI-29125
MNDR hsa-miR-214-3p Intrahepatic cholangiocarcinoma MNDR-E-MI-29126
MNDR hsa-miR-214-3p Cholangiocarcinoma MNDR-E-MI-29127
MNDR hsa-miR-214-3p Esophageal cancer MNDR-E-MI-29128
MNDR hsa-miR-214-3p Oncocytoma MNDR-E-MI-29129
MNDR hsa-miR-214-3p Lung small cell carcinoma MNDR-E-MI-29130
MNDR hsa-miR-214-3p Synovial sarcoma MNDR-E-MI-29131
MNDR hsa-miR-214-3p Head and neck squamous cell carcinoma MNDR-E-MI-29132
MNDR hsa-miR-214-3p Heart failure MNDR-E-MI-29133
MNDR hsa-miR-214-3p Pulmonary hypertension MNDR-E-MI-29134
MNDR hsa-miR-214-3p Adenoma MNDR-E-MI-29135
MNDR hsa-miR-214-3p Breast invasive carcinoma MNDR-E-MI-29136
MNDR hsa-miR-214-3p Hepatocellular carcinoma MNDR-E-MI-29137
MNDR hsa-miR-214-3p Embryonal cancer MNDR-E-MI-29138
MNDR hsa-miR-214-3p B-cell lymphoma MNDR-E-MI-29139
MNDR hsa-miR-214-3p Neuroblastoma MNDR-E-MI-29140
MNDR hsa-miR-214-3p Periodontitis MNDR-E-MI-29141
MNDR hsa-miR-214-3p Hodgkin lymphoma MNDR-E-MI-29142
MNDR hsa-miR-214-3p Ulcerative colitis MNDR-E-MI-29143
MNDR hsa-miR-214-3p Burkitt lymphoma MNDR-E-MI-29144
MNDR hsa-miR-214-3p Tonsil cancer MNDR-E-MI-29145
MNDR hsa-miR-214-3p Colorectal cancer MNDR-E-MI-29146
MNDR hsa-miR-214-3p Multiple myeloma MNDR-E-MI-29147
MNDR hsa-miR-214-3p Nasopharyngeal disease MNDR-E-MI-29148
MNDR hsa-miR-214-3p Uterine cervical neoplasms MNDR-E-MI-29149
MNDR hsa-miR-214-3p Cardiomegaly MNDR-E-MI-29150
MNDR hsa-miR-214-3p Nasopharyngeal cancer MNDR-E-MI-29151
MNDR hsa-miR-214-3p Prostatic neoplasms MNDR-E-MI-29152
MNDR hsa-miR-214-3p Lymphoma t-cell MNDR-E-MI-29153
MNDR hsa-miR-214-3p Polymyositis MNDR-E-MI-29154
MNDR hsa-miR-214-3p Stroke lacunar MNDR-E-MI-29155
MNDR hsa-miR-214-3p Breast cancer her3+ negative MNDR-E-MI-29156
MNDR hsa-miR-214-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-29157
MNDR hsa-miR-214-3p Tubulovillous adenoma MNDR-E-MI-29158
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter AIFM2 Homo sapiens RR00059432
TOP